Position in VTRS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$20,658,343
+$2,745,134 QoQ
Shares Held
1,529,115
+6.3% QoQ
Ownership
0.131%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026STATE OF WISCONSIN INVESTMENT BOARD holds $146,075,839 across 40 Drug Manufacturers - Specialty & Generic names. VTRS ranks #2 (14.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
236,309 | $27,934,086 | |
| 2 | VTRS |
Viatris Inc
This page
|
1,529,115 | $20,658,343 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
96,261 | $12,681,424 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
21,326 | $12,645,891 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
361,622 | $10,892,054 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
126,437 | $9,590,246 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
313,166 | $7,494,062 | |
| 8 | ALKS |
Alkermes plc.
|
139,333 | $4,926,814 |
All Filings in VTRS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $20,658,343 | 1,529,115 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $17,913,209 | 1,438,812 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $16,517,496 | 1,668,434 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $14,503,105 | 1,624,088 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $13,708,660 | 1,573,899 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $14,216,816 | 1,141,913 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $17,438,034 | 1,501,984 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $13,888,435 | 1,306,532 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $17,653,815 | 1,478,544 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $15,495,390 | 1,430,784 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $11,321,054 | 1,148,180 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $10,082,225 | 1,010,243 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $13,997,455 | 1,455,037 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $7,768,439 | 697,973 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $7,125,932 | 836,377 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $9,111,329 | 870,232 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $9,593,407 | 881,747 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $20,898,979 | 1,544,640 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $27,213,779 | 2,008,397 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $34,315,205 | 2,401,344 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $23,319,310 | 1,669,242 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $37,934,426 | 2,024,249 | Shares | Sole | 2021-02-03 | |
| No filing history on record for this holder in this stock. | ||||||